Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- A8503 PiroxicamTarget: COX|Prostaglandin synthesisSummary: Prostaglandin synthesis/Coxinhibitor
- A8514 RisperidoneSummary: SR-2A inhibitor
- A8515 Rivastigmine TartrateSummary: AChR inhibitor
- A8516 Rizatriptan BenzoateSummary: 5-HT Receptor agonist
- A8384 BlonanserinSummary: Atypical antipsychotic
- A8389 Carbenoxolone disodium1 CitationTarget: Gap JunctionsSummary: 11β-HSD inhibitor
- A8398 ChlorprothixeneSummary: Dopamine receptor antagonist
- A8414 Diphemanil MethylsulfateSummary: AChR antagonist
- A8421 Duloxetine HClSummary: 5-HT receptor inhibitor
- A8451 Ipratropium BromideSummary: AChR antagonist